About quantum si inc - QSI
Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. It engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins in a massively parallel fashion. Its platform includes platinum NGPS instrument, platinum analysis software, and consumable kits for platinum instrument. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.
QSI At a Glance
Quantum-Si, Inc.
29 Business Park Drive
Branford, Connecticut 06405
| Phone | 1-866-688-7374 | Revenue | 2.44M | |
| Industry | Packaged Software | Net Income | -101,339,000.00 | |
| Sector | Technology Services | Employees | 145 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
QSI Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 89.303 |
| Price to Book Ratio | 1.081 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.635 |
| Enterprise Value to Sales | 24.137 |
| Total Debt to Enterprise Value | 0.071 |
QSI Efficiency
| Revenue/Employee | 16,800.00 |
| Income Per Employee | -698,889.655 |
| Receivables Turnover | 0.413 |
| Total Asset Turnover | 0.01 |
QSI Liquidity
| Current Ratio | 7.638 |
| Quick Ratio | 7.499 |
| Cash Ratio | 7.075 |
QSI Profitability
| Gross Margin | -135.509 |
| Operating Margin | -3,983.908 |
| Pretax Margin | -4,157.677 |
| Net Margin | -4,160.057 |
| Return on Assets | -41.00 |
| Return on Equity | -46.524 |
| Return on Total Capital | -45.162 |
| Return on Invested Capital | -45.32 |
QSI Capital Structure
| Total Debt to Total Equity | 1.892 |
| Total Debt to Total Capital | 1.857 |
| Total Debt to Total Assets | 1.69 |
| Long-Term Debt to Equity | 1.054 |
| Long-Term Debt to Total Capital | 1.035 |